|
|
|||
|
||||
OverviewThis monograph explains the considerable impact that monoclonal antibodies and molecular probes have had on the diagnosis of tumor types and sub-types. It explains how radiolabelled monoclonal antibodies have also been used as imaging agents to try to improve the oncologist's ability to define residual tumor deposits after combination chemo/radiotherapy. Finally, the childhood malignancies that still have a poor prognosis are presented, and new novel ways of therapy are explained. Full Product DetailsAuthor: John T. KemsheadPublisher: Taylor & Francis Ltd Imprint: CRC Press Weight: 0.453kg ISBN: 9780367451066ISBN 10: 0367451069 Pages: 199 Publication Date: 29 October 2020 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: In Print This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviews...""up-to-date, comprehensive, and thought-provoking."" -Acta Oncologica ... up-to-date, comprehensive, and thought-provoking. -Acta Oncologica Author InformationJohn T Kemshead Tab Content 6Author Website:Countries AvailableAll regions |
||||